| Cassandra Len, | |
|
103 Commercial St, Brockton, MA 02302-3101 | |
| (603) 320-4485 | |
| Not Available |
| Full Name | Cassandra Len |
|---|---|
| Gender | Female |
| Speciality | Counselor - Mental Health |
| Location | 103 Commercial St, Brockton, Massachusetts |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023463718 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YM0800X | Counselor - Mental Health | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Cassandra Len, 764 Mount Auburn St, Watertown, MA 02472-1525 Ph: () - | Cassandra Len, 103 Commercial St, Brockton, MA 02302-3101 Ph: (603) 320-4485 |
News Archive
"The HIV infection rate has declined among pregnant women in the Republic of Congo from 3.4 percent in 2009 to 2.8 percent in 2012, according to a study by the Ministry of Health, which said it had taken specific action to help this section of the population," PlusNews reports.
As childhood and adolescent deaths from infectious diseases have declined worldwide, policymakers are shifting attention to preventing deaths from noncommunicable causes, such as drug and alcohol use, mental health problems, obesity, traffic crashes, violence and unsafe sex practices.
Boehringer Ingelheim Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) approved the supplemental New Drug Application (sNDA) for its angiotensin II receptor blocker (ARB) Micardis® (telmisartan) Tablets 80 mg for reduction of the risk of myocardial infarction, stroke, or death from cardiovascular causes in patients 55 years of age or older at high risk of developing major cardiovascular events who are unable to take angiotensin-converting enzyme (ACE) inhibitors.(1) MICARDIS is the most studied ARB in this high-risk patient population and has been commercially available to treat hypertension (high blood pressure) since its approval in 1998.
Arcion Therapeutics, a venture backed clinical stage biotechnology company developing topical therapies for chronic pain, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to ARC-4558 for the treatment of pain associated with Painful Diabetic Neuropathy (PDN).
Calixa Therapeutics Inc., a clinical-stage biopharmaceutical company focused on the development and commercialization of novel antibiotics for the treatment of antibiotic-resistant infections, will present pre-clinical and clinical data in 20 posters at the Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) that is being held in San Francisco on September 12 to 15, 2009.
› Verified 6 days ago
Mrs. Neena Nicole Mcconnico, M.A., LMHC Counselor Medicare: Not Enrolled in Medicare Practice Location: 95 River St, Brockton, MA 02302 Phone: 508-580-8546 | |
Cecilia Vicente, Counselor Medicare: Not Enrolled in Medicare Practice Location: 231 Main St, Suite 300, Brockton, MA 02301 Phone: 508-586-2660 Fax: 508-427-1505 | |
Krista Hojlo, MSW, LCSW Counselor Medicare: Not Enrolled in Medicare Practice Location: 67 Brian Dr, Brockton, MA 02301 Phone: 508-245-1566 | |
Pamela Cummisky, Counselor Medicare: Not Enrolled in Medicare Practice Location: 30 Meadowbrook Rd, Brockton, MA 02301 Phone: 774-628-1000 | |
Thalia Dominguez, NREMT, MS Counselor Medicare: Not Enrolled in Medicare Practice Location: 56 Cherry St, Brockton, MA 02301 Phone: 508-580-0801 | |
Deborah G Stromberg, Counselor Medicare: Not Enrolled in Medicare Practice Location: 37 Belmont St, Brockton, MA 02301 Phone: 508-580-4691 Fax: 508-588-5751 | |
Dennis Dipinto, LMHC Counselor Medicare: Medicare Enrolled Practice Location: 529 Pearl St, Brockton, MA 02301 Phone: 508-580-2211 |